Novartis bolsters Neuroscience pipeline with in-licensing of PTC518 for Huntington's disease Ruchika Sharma3 Dec 2024 1:30 PM ISTBasel: Novartis has announced that it has entered into a global license and collaboration agreement with PTC Therapeutics for PTC518.PTC518 is an...
Sage Therapeutics' Experimental Drug for Huntington's Disease Fails Mid-Stage Trial Farhat Nasim21 Nov 2024 11:30 AM ISTThe drug, dalzanemdor, did not significantly improve cognitive function in patients compared to placebo after 84 days, failing to meet the main goal
Study finds that an imbalance in cholesterol may be linked to neurodegeneration, suggesting potential strategies for intervention Dr. Garima Soni6 Aug 2024 8:15 AM ISTIn a recent review published in the journal Experimental & Molecular Medicine, researchers reviewed available literature on the role and...
Voyager Therapeutics enters Capsid license agreement with Novartis to advance novel gene therapies Ruchika Sharma3 Jan 2024 2:37 PM ISTUnder the terms of the agreement, Novartis has agreed to pay Voyager $100 million of consideration up front, including a $20 million purchase of newly...
Medical Bulletin 27/May/2023 Isra Zaman27 May 2023 4:30 PM ISTHere are the top medical news for the day:Eating natto might help to distressHealth is wealth as the saying goes and new research now shows that it is...
Valbenazine significantly reduces chorea symptoms in Huntington's disease Dr. Kamal Kant Kohli22 May 2023 8:00 PM ISTThe drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington's disease, when compared to a placebo,...
Medical Bulletin 27/December/2022 Isra Zaman27 Dec 2022 2:45 PM ISTHere are the top medical news for the day:Novel bacterial therapy approach for treating lung cancerColumbia Engineering researchers report that they...
Unique cellular hallmarks found in 6 neurodegenerative diseases Isra Zaman27 Dec 2022 9:30 AM ISTIn a study appearing in the current issue ofAlzheimer's & Dementia: The Journal of the Alzheimer' Association,corresponding author Carol Huseby of...
Teva resolves patent dispute with Aurobindo pharma over Huntingtons disease drug AUSTEDO Susmita Roy10 Jun 2022 7:06 PM ISTBringing the long argument to a conclusion, Teva Branded Pharmaceutical Products R&D, and Auspex Pharmaceuticals,U.S. affiliates of Teva...
Valbenazine benefits patients with Huntington's disease-associated chorea Dr. Kamal Kant Kohli19 April 2022 9:00 AM IST A new drug has proven beneficial in treating a movement disorder commonly associated with Huntington's disease, according to a recent...
